New hope: HIV drug studied in liver transplant patients
NCT ID NCT01022476
First seen Apr 13, 2026 · Last updated May 15, 2026 · Updated 4 times
Summary
This study looked at how the HIV medicine raltegravir works in people with severe liver failure who need a liver transplant. It included 14 HIV-positive adults with end-stage liver disease. Researchers measured how the drug behaves in the body and checked for interactions with anti-rejection medicines after transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Service de Médecine Interne, Hôpital de Bicêtre
Le Kremlin-Bicêtre, 94275, France
Conditions
Explore the condition pages connected to this study.